Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/11/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/11/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/11/2012
U.T. Southwestern Medical Center
mi
from
Dallas, TX
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/11/2012
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/11/2012
Swedish Medical Center
mi
from
Seattle, WA
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)
A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/11/2012
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 208 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
San Diego, CA
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 208 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 208 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
St Louis, MO
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 208 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
St Louis, MO
Click here to add this to my saved trials
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 208 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Houston, TX
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
A Phase 1, First-In-Human Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 208 in Adult Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
BKM120 in Cancers With PIK3CA Activating Mutations
An Open Label, Phase II Trial of BKM120 in Cancers With PIK3CA Activating Mutations
Status: Enrolling
Updated:  7/12/2012
Massachusetts General Hospital
mi
from
Boston, MA
BKM120 in Cancers With PIK3CA Activating Mutations
An Open Label, Phase II Trial of BKM120 in Cancers With PIK3CA Activating Mutations
Status: Enrolling
Updated: 7/12/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery
Mechanically-Manipulated Transrectal Ultrasound (TRUS) During Robotic-Assisted Laparoscopic Prostatectomy (RALP)
Status: Enrolling
Updated:  7/14/2012
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery
Mechanically-Manipulated Transrectal Ultrasound (TRUS) During Robotic-Assisted Laparoscopic Prostatectomy (RALP)
Status: Enrolling
Updated: 7/14/2012
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Status: Enrolling
Updated:  7/16/2012
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
Status: Enrolling
Updated: 7/16/2012
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
A Comparative, Multicenter, Open-Label, Randomized, Phase 2 Study of the Safety and Antitumor Activity of Oral Eniluracil + 5 Fluorouracil + Leucovorin Versus Capecitabine Monotherapy in Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/16/2012
Banner MD Anderson Cancer Center
mi
from
Gilbert, AZ
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
A Comparative, Multicenter, Open-Label, Randomized, Phase 2 Study of the Safety and Antitumor Activity of Oral Eniluracil + 5 Fluorouracil + Leucovorin Versus Capecitabine Monotherapy in Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/16/2012
Banner MD Anderson Cancer Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
A Comparative, Multicenter, Open-Label, Randomized, Phase 2 Study of the Safety and Antitumor Activity of Oral Eniluracil + 5 Fluorouracil + Leucovorin Versus Capecitabine Monotherapy in Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/16/2012
The Methodist Hospital Cancer Center
mi
from
Houston, TX
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
A Comparative, Multicenter, Open-Label, Randomized, Phase 2 Study of the Safety and Antitumor Activity of Oral Eniluracil + 5 Fluorouracil + Leucovorin Versus Capecitabine Monotherapy in Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/16/2012
The Methodist Hospital Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2, Open-Label, Single-Arm, Multidose Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling
Updated:  7/16/2012
Pinnacle Oncology
mi
from
Scottsdale, AZ
Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2, Open-Label, Single-Arm, Multidose Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling
Updated: 7/16/2012
Pinnacle Oncology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  7/18/2012
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 7/18/2012
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  7/18/2012
The West Clinic, PC
mi
from
Memphis, TN
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 7/18/2012
The West Clinic, PC
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  7/18/2012
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 7/18/2012
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated:  7/18/2012
Northwest Cancer Specialists
mi
from
Vancouver, WA
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Phase I/II Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Status: Enrolling
Updated: 7/18/2012
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Phase II Trial of Lapatinib in Combination With Everolimus in Triple Negative Metastatic or Locally Advanced Breast Cancer
Status: Enrolling
Updated:  7/19/2012
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Phase II Trial of Lapatinib in Combination With Everolimus in Triple Negative Metastatic or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 7/19/2012
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Phase II Trial of Lapatinib in Combination With Everolimus in Triple Negative Metastatic or Locally Advanced Breast Cancer
Status: Enrolling
Updated:  7/19/2012
Emory Midtown (Crawford Long Hospital)
mi
from
Atlanta, GA
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Phase II Trial of Lapatinib in Combination With Everolimus in Triple Negative Metastatic or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 7/19/2012
Emory Midtown (Crawford Long Hospital)
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Phase II Trial of Lapatinib in Combination With Everolimus in Triple Negative Metastatic or Locally Advanced Breast Cancer
Status: Enrolling
Updated:  7/19/2012
Grady Memorial Hospital
mi
from
Atlanta, GA
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Phase II Trial of Lapatinib in Combination With Everolimus in Triple Negative Metastatic or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 7/19/2012
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
A Phase I, Open-label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Oral Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Status: Enrolling
Updated:  7/19/2012
University of Utah / Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
A Phase I, Open-label, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Oral Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function
Status: Enrolling
Updated: 7/19/2012
University of Utah / Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked Cigarettes
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
Status: Enrolling
Updated:  7/19/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked Cigarettes
Survey and Blood Sample Collection for Patients With Lung Cancer Who Never Smoked Cigarettes
Status: Enrolling
Updated: 7/19/2012
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated:  7/19/2012
Eastern Maine Medical Center
mi
from
Bangor, ME
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated: 7/19/2012
Eastern Maine Medical Center
mi
from
Bangor, ME
Click here to add this to my saved trials
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated:  7/19/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated: 7/19/2012
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated:  7/19/2012
Lowell General Hospital
mi
from
Lowell, MA
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated: 7/19/2012
Lowell General Hospital
mi
from
Lowell, MA
Click here to add this to my saved trials
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated:  7/19/2012
Texas Oncology Cancer Center
mi
from
Austin, TX
Pilot Study for Young Women's Intervention
Qualitative Assessment and Pilot Study for Young Women's Intervention
Status: Enrolling
Updated: 7/19/2012
Texas Oncology Cancer Center
mi
from
Austin, TX
Click here to add this to my saved trials
Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy
Integration of an Electronic Education System Into Colonoscopy: Improving Education, Consent and Compliance of Patients at Colonoscopy With an Ipad-based Secure Video Intervention
Status: Enrolling
Updated:  7/19/2012
Johns Hopkins University
mi
from
Baltimore, MD
Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy
Integration of an Electronic Education System Into Colonoscopy: Improving Education, Consent and Compliance of Patients at Colonoscopy With an Ipad-based Secure Video Intervention
Status: Enrolling
Updated: 7/19/2012
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  7/20/2012
University of Michigan Health System
mi
from
Ann Arbor, MI
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 7/20/2012
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  7/20/2012
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 7/20/2012
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  7/20/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 7/20/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  7/20/2012
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
A Phase II Study of Single-agent Tesetaxel in Chemotherapy-naive Patients Who Have Progressive, Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 7/20/2012
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/20/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/20/2012
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/20/2012
The Moses H. Cone Regional Cancer Center
mi
from
Greensboro, NC
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/20/2012
The Moses H. Cone Regional Cancer Center
mi
from
Greensboro, NC
Click here to add this to my saved trials
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/20/2012
The West Clinic, PC
mi
from
Memphis, TN
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/20/2012
The West Clinic, PC
mi
from
Memphis, TN
Click here to add this to my saved trials
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/20/2012
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Tesetaxel as First-line Therapy for Metastatic Breast Cancer
A Phase II Study of Tesetaxel as First-line Therapy for Subjects With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/20/2012
Texas Oncology-Baylor Charles A. Sammons Cancer Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Wilshire Oncology Medical Group
mi
from
La Verne, CA
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Wilshire Oncology Medical Group
mi
from
La Verne, CA
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Tampa General Hospital
mi
from
Tampa, FL
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
DiaTech Oncology
mi
from
Brentwood, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
DiaTech Oncology
mi
from
Brentwood, TN
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Cumberland Medical Center
mi
from
Crossville, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Cumberland Medical Center
mi
from
Crossville, TN
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Middle Tennessee Medical Center
mi
from
Murfreesboro, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Middle Tennessee Medical Center
mi
from
Murfreesboro, TN
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Nashville Oncology Associates
mi
from
Nashville, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Nashville Oncology Associates
mi
from
Nashville, TN
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Baptist Hospital
mi
from
Nashville, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Baptist Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
St. Thomas Research Institute, LLC
mi
from
Nashville, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
St. Thomas Research Institute, LLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Tennessee Breast Specialists
mi
from
Nashville, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Tennessee Breast Specialists
mi
from
Nashville, TN
Click here to add this to my saved trials
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated:  7/23/2012
Tennessee Toracic Surgical Specialists
mi
from
Nashville, TN
Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Correlation of the Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients
Status: Enrolling
Updated: 7/23/2012
Tennessee Toracic Surgical Specialists
mi
from
Nashville, TN
Click here to add this to my saved trials
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2012
Ironwood Cancer and Research Center
mi
from
Chandler, AZ
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2012
Ironwood Cancer and Research Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2012
Arizona Oncology Associates
mi
from
Tucson, AZ
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2012
Arizona Oncology Associates
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2012
University of California, Irvine Medical Center
mi
from
Orange, CA
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2012
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2012
PMK Medical Group, Inc.
mi
from
Oxnard, CA
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2012
PMK Medical Group, Inc.
mi
from
Oxnard, CA
Click here to add this to my saved trials
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2012
Wilshire Oncology Medical Group, Inc.
mi
from
Pomona, CA
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2012
Wilshire Oncology Medical Group, Inc.
mi
from
Pomona, CA
Click here to add this to my saved trials
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  7/23/2012
American Institute of Research
mi
from
Whittier, CA
A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 7/23/2012
American Institute of Research
mi
from
Whittier, CA
Click here to add this to my saved trials